MPXI — MPX International Income Statement
0.000.00%
HealthcareSpeculativeMicro Cap
Annual income statement for MPX International, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2018 September 30th | 2019 September 30th | 2020 September 30th | 2021 September 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0.064 | 1.59 | 3.17 | 7.21 |
| Cost of Revenue | ||||
| Gross Profit | 0.03 | 1.3 | 2.6 | 4.72 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 2.15 | 11.5 | 43.9 | 29.2 |
| Operating Profit | -2.08 | -9.91 | -40.7 | -22 |
| Total Net Non Operating Interest Income / Expense | ||||
| Gain / Loss on Sale of Assets | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -2.11 | -9.12 | -41.7 | -26.4 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -2.11 | -9.38 | -41 | -26.6 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -2.11 | -9.26 | -40.7 | -25.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -2.11 | -9.26 | -40.7 | -25.6 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.047 | -0.166 | -0.172 | -0.144 |